NCT04709887

Brief Summary

This cohort study aims to evaluate the outcomes of appropriate surgical treatment strategies in diabetic foot ulcers with different rate of popliteal artery stenosis(\<50% or ≥50%). In this study, patients with Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers will be included. Data of patients who underwent surgical treatment in the past will be retrospectively collected. The patients with follow-up time less than 12 months will continue to follow up. Also the postoperative patients will be prospectively collected. Effects of different surgical strategies, including wound healing therapy, interventional therapy and tibial transverse bone transport therapy will be measured by several indexes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
332

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

January 12, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 14, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

January 19, 2021

Status Verified

January 1, 2021

Enrollment Period

5 years

First QC Date

January 12, 2021

Last Update Submit

January 14, 2021

Conditions

Keywords

Ischemic Diabetic Foot UlcerSurgical StrategyCohort study

Outcome Measures

Primary Outcomes (1)

  • Healing rate of wound surface

    12 months after surgical operation

Secondary Outcomes (3)

  • Ankle-brachial index

    3 months after surgical operation

  • Ankle-brachial index

    12 months after surgical operation

  • Recurrence rate of foot ulcer

    12 months after surgical operation

Study Arms (5)

Rate of popliteal artery stenosis < 50%, W.

OTHER

If the rate of popliteal artery stenosis of patients \< 50%, the patients only receive the wound treatment.

Procedure: Wound treatment

Rate of popliteal artery stenosis < 50%, WT.

OTHER

If the rate of popliteal artery stenosis of patients \< 50%, the patients receive the wound treatment and tibial transverse transport surgery.

Procedure: Wound treatmentProcedure: Tibial transverse transport surgery

Rate of popliteal artery stenosis ≥ 50%, WV.

OTHER

If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and vascular intervention surgery.

Procedure: Wound treatmentProcedure: Vascular intervention surgery

Rate of popliteal artery stenosis ≥ 50%, WT.

OTHER

If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and tibial transverse transport surgery.

Procedure: Wound treatmentProcedure: Tibial transverse transport surgery

Rate of popliteal artery stenosis ≥ 50%, WVT.

OTHER

If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment, vascular intervention and tibial transverse transport surgery.

Procedure: Wound treatmentProcedure: Vascular intervention surgeryProcedure: Tibial transverse transport surgery

Interventions

According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial.

Rate of popliteal artery stenosis < 50%, W.Rate of popliteal artery stenosis < 50%, WT.Rate of popliteal artery stenosis ≥ 50%, WT.Rate of popliteal artery stenosis ≥ 50%, WV.Rate of popliteal artery stenosis ≥ 50%, WVT.

Segmented distal angiography under the guidance of digital subtraction angiography (DSA) were perform after local anesthesia. The superficial artery is expanded by a 3-4 mm balloon.

Rate of popliteal artery stenosis ≥ 50%, WV.Rate of popliteal artery stenosis ≥ 50%, WVT.

In the anteromedial area of the proximal tibia of the affected limb, the external fixation frame was compared with the area along the midline of the medial longitudinal axis of the proximal tibia. Subsequently, two 3.0 Steinmann pins were inserted through the single layer of cortical bone. The skin was cut along the long axis with the 3.0 Steinmann pin as the centre, and the subcutaneous tissue was separate bluntly to expose the periosteum. The Steinmann pins were used as the centre point for the drilling on four sides with a 2.0 drill bit and use of a rapid osteotomy device; the length of each side was 2.5 cm. Subperiosteal osteotomy was performed with a 5-mm narrow bone knife at an angle of 15°-30° to the bone surface. The surgeons should pay attention to protect the blood supply of the periosteum during this procedure. The external fixators were fixed with 4.0 Steinmann pins at the distal and proximal ends. The subcutaneous tissue and skin were sutured.

Rate of popliteal artery stenosis < 50%, WT.Rate of popliteal artery stenosis ≥ 50%, WT.Rate of popliteal artery stenosis ≥ 50%, WVT.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with diabetic foot, according to "Chinese Guidelines for Diagnosis and Treatment of Diabetic Foot (2017)".
  • Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers.
  • Have clear consciousness, not suffer from mental illness, can cooperate in research and treatment.
  • Patients who are informed, participate in the research voluntarily, and have signed the informed consent.
  • Have complete clinical data.

You may not qualify if:

  • Patients with severe systemic infection, who need to be amputated immediately to save lives.
  • Patients with mental illness, who cannot cooperate to complete the adjustment and nursing of the external fixator.
  • Patients with severe cardiovascular and cerebrovascular diseases (such as severe cardiac insufficiency, severe sequelae of cerebrovascular disease), or with acute infectious diseases.
  • Have used or using glucocorticoids systemically within 3 months before admission.
  • Have participated in other medical clinical trials within 3 months before admission.
  • Patients with severe liver or kidney function abnormalities
  • Pregnant or lactating women.
  • Patients who lost follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University People's Hospital

Beijing, China

RECRUITING

MeSH Terms

Conditions

Diabetic Foot

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Officials

  • Hailin Xu, MD

    Peking University People's Hospital

    STUDY DIRECTOR

Central Study Contacts

Yusong Yuan, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 12, 2021

First Posted

January 14, 2021

Study Start

January 1, 2017

Primary Completion

January 1, 2022

Study Completion

January 1, 2024

Last Updated

January 19, 2021

Record last verified: 2021-01

Locations